Dashboard
Manage Tickers

ZURA


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

zura-bio-ceo-robert-lisicki-to-take-medical-leave-kim-davis-appointed-interim-ceo
Zura Bio CEO Robert Lisicki To Take Medica...
10/10/2025 12:24:51

-SEC Filing

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
09/30/2025 17:06:34

chardan-capital-maintains-buy-on-zura-bio-maintains-10-price-target
Chardan Capital Maintains Buy on Zura Bio,...
09/30/2025 11:19:59

Chardan Capital analyst Daniil Gataulin maintains Zura Bio (NASDAQ:ZURA) with a Buy and maintains $10 price target.

Core News & Articles
12 Health Care Stocks Moving In Monday's I...
09/29/2025 17:06:50

Gainers cbdMD (AMEX:YCBD) shares rose 116.3% to $1.35 during Monday's regular session. The company's market cap stands...

Core News & Articles
12 Health Care Stocks Moving In Monday's P...
09/29/2025 12:09:33

Gainers Dogwood Therapeutics (NASDAQ: DWTX) stock moved upwards by 80.1% to $9.94 during Monday's pre-market session. The ...

why-merus-shares-are-trading-higher-by-38-here-are-20-stocks-moving-premarket
Why Merus Shares Are Trading Higher By 38%...
09/29/2025 09:07:53

Shares of Merus NV (NASDAQ: MRUS) rose sharply in today's pre-market trading. Genmab announced plans to acquire Merus fo...

hc-wainwright--co-maintains-neutral-on-zura-bio-lowers-price-target-to-2
HC Wainwright & Co. Maintains Neutral on Z...
08/19/2025 10:55:37

HC Wainwright & Co. analyst Mitchell S. Kapoor maintains Zura Bio (NASDAQ:ZURA) with a Neutral and lowers the price targ...

oppenheimer-maintains-outperform-on-zura-bio-lowers-price-target-to-16
Oppenheimer Maintains Outperform on Zura B...
08/15/2025 14:37:58

Oppenheimer analyst Justin Kim maintains Zura Bio (NASDAQ:ZURA) with a Outperform and lowers the price target from $17 to $16.

chardan-capital-maintains-buy-on-zura-bio-maintains-10-price-target
Chardan Capital Maintains Buy on Zura Bio,...
08/15/2025 12:09:09

Chardan Capital analyst Daniil Gataulin maintains Zura Bio (NASDAQ:ZURA) with a Buy and maintains $10 price target.

zura-bio-q2-eps-017-beats-018-estimate
Zura Bio Q2 EPS $(0.17) Beats $(0.18) Esti...
08/14/2025 12:21:34

Zura Bio (NASDAQ:ZURA) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.18) by 7...

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
07/17/2025 17:06:01

zura-bio-appoints-eric-hyllengren-as-cfo-succeeding-verender-badial-effective-july-7-2025
Zura Bio Appoints Eric Hyllengren As CFO, ...
07/01/2025 10:31:42

zura-bio-launches-global-phase-2-tibushield-study-to-evaluate-tibulizumab-in-adults-with-hidradenitis-suppurativa-topline-results-for-primary-efficacy-endpoint-at-week-16-along-with-key-secondary-and-exploratory-outcomes-are-anticipated-in-third-quarter-of-2026
Zura Bio Launches Global Phase 2 TibuSHIEL...
05/20/2025 10:34:51

oppenheimer-maintains-outperform-on-zura-bio-lowers-price-target-to-17
Oppenheimer Maintains Outperform on Zura B...
05/09/2025 17:50:19

Oppenheimer analyst Jeff Jones maintains Zura Bio (NASDAQ:ZURA) with a Outperform and lowers the price target from $19 to $17.

zura-bio-q1-eps-019-misses-015-estimate
Zura Bio Q1 EPS $(0.19) Misses $(0.15) Est...
05/08/2025 10:40:19

hc-wainwright--co-maintains-neutral-on-zura-bio-lowers-price-target-to-3
HC Wainwright & Co. Maintains Neutral on Z...
04/03/2025 11:02:26

HC Wainwright & Co. analyst Mitchell Kapoor maintains Zura Bio (NASDAQ:ZURA) with a Neutral and lowers the price target ...

oppenheimer-maintains-outperform-on-zura-bio-lowers-price-target-to-19
Oppenheimer Maintains Outperform on Zura B...
03/26/2025 17:02:44

Oppenheimer analyst Jeff Jones maintains Zura Bio (NASDAQ:ZURA) with a Outperform and lowers the price target from $20 to $19.

guggenheim-reiterates-buy-on-zura-bio-maintains-15-price-target
Guggenheim Reiterates Buy on Zura Bio, Mai...
03/26/2025 13:44:37

Guggenheim analyst Yatin Suneja reiterates Zura Bio (NASDAQ:ZURA) with a Buy and maintains $15 price target.

chardan-capital-maintains-buy-on-zura-bio-lowers-price-target-to-10
Chardan Capital Maintains Buy on Zura Bio,...
03/26/2025 12:02:19

Chardan Capital analyst Matthew Barcus maintains Zura Bio (NASDAQ:ZURA) with a Buy and lowers the price target from $12 to $10.

zura-bio-posts-fy24-net-loss-of-060
Zura Bio Posts FY24 Net Loss Of $0.60
03/25/2025 10:47:05

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION